Abstract:Abstract Background and purpose: Giant cell tumor of bone (GCTB) is a locally aggressive tumor with metastatic potential. Given that GCTBs are composed of three major cell populations and the bone-resorption activity is attributed to the multinucleated giant cells which are conjectured to be recruited by “real” tumor cells, it is still elusive that how and what are these immune cells recruited. The purpose of this study is to present the immune landscape of GCTB, as well as to find out responsible chemokines during immune cell recruiting. Experimental procedures: We collected fresh GCTB tissues from surgical excisions. To identify immune cell composition within the tumor microenvironment, we performed mass cytometry (CyTOF) and conventional multicolor cytometry. Some fresh osteosarcoma and chondrosarcoma samples were also used to compare the immune atlas. For chemokine profiling, chemokine arrays were utilized. Further analysis on potential association between chemokines and immune cells were conducted. Results: For last updated, 47 GCTB fresh samples were collected, of which 12 cases received CyTOF analysis and the rest 35 samples were analyzed by multicolor cytometry. All GCTB samples were analyzed by chemokine array In-depth interrogation of the immune landscapes showed that compared with osteosarcoma and chondrosarcoma, GCTBs had some unique immune cell subgroups. Some CD163+ CD206+ macrophage clusters which expressed various immune suppressive markers were significantly enriched in GCTBs, while CD4+ CD25+ Treg cells were fewer in GCTB. In addition, some macrophage-like mononuclear cells (CD14- CD68+ CD163- CD206+ HLA-DR+) were only seen in GCTBs.Chemokine array revealed that higher levels of CXCL12, CCL22, and CCL7 might be associated with moremacrophage-like mononuclear cells in GCTBs. Conclusion: GCTB have very different immune features from other malignant bone tumors. Multiple chemokines may play important roles in recruiting “functional” monocytes. Such in-depth understanding has important implications in appropriate therapeutics for GCTB. Bigger sample size will further help in studying the immune and chemokine features of GCTB. Note: This abstract was not presented at the meeting. Citation Format: Binghao Li, Zhan Wang, Zhaoming Ye. The immune atlas and chemokine profile of giant cell tumor of bone [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1486.

Biological characteristics of a novel giant cell tumor cell line derived from spine

Establishment and characterization of NCC-GCTB14-C1 and NCC-GCTB15-C1: two novel patient-derived cell lines of giant cell tumor of bone

Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1

Establishment and characterization of NCC-GCTB10-C1: a novel cell line derived from a patient with recurrent giant cell tumor of bone

Imaging Features, Staging System, and Surgical Management of Giant Cell Lesions of the Temporal Bone.

Serglycin Induces Osteoclastogenesis and Promotes Tumor Growth in Giant Cell Tumor of Bone.

Genome-Wide Transcriptome Profiling Of The Neoplastic Giant Cell Tumor Of Bone Stromal Cells By Rna Sequencing

Abstract 1486: the Immune Atlas and Chemokine Profile of Giant Cell Tumor of Bone

ALCAM + stromal cells: role in giant cell tumor of bone progression

Clinicopathologic and prognostic characteristics of tumor budding-like in giant cell tumor of bone

Rare features of giant cell tumors of the bone: A case report

Histological and clinical characteristics of malignant giant cell tumor of bone

Factors related to biologic behavior in giant cell tumor of bone

TRAIL-R1 As a Novel Surface Marker for Circulating Giant Cell Tumor of Bone

Stro-1(+) Stromal Cells Have Stem-Like Features In Giant Cell Tumor Of Bone

Expressions and Clinical Significance of Factors Related to Giant Cell Tumor of Bone

Giant cell tumor of bone revisited

Gene Expression Disparity in Giant Cell Tumor of Bone

A Retrospective Observational Study on Disease Characteristics and Treatment Patterns of Giant Cell Tumor of the Bone in China.

Expression and Clinical Significance of Protein CD133 in Giant Cell Tumor of Bone

Giant Cell Tumour of the Tendon Sheath of the Spine: Clinical Features and Imaging Findings